Shattuck Labs, Inc. (STTK)
4.595
-0.06
(-1.39%)
USD |
NASDAQ |
Nov 17, 16:00
4.45
-0.14
(-3.16%)
After-Hours: 20:00
Shattuck Labs Shareholders Equity (Quarterly) : 193.66M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 193.66M |
| June 30, 2026 | 211.14M |
| March 31, 2026 | 95.84M |
| December 31, 2025 | 82.39M |
| September 30, 2025 | 93.24M |
| June 30, 2025 | 57.02M |
| March 31, 2025 | 67.59M |
| December 31, 2024 | 79.63M |
| September 30, 2024 | 96.58M |
| June 30, 2024 | 110.62M |
| March 31, 2024 | 128.81M |
| December 31, 2023 | 144.70M |
| September 30, 2023 | 112.78M |
| June 30, 2023 | 138.46M |
| Date | Value |
|---|---|
| March 31, 2023 | 157.65M |
| December 31, 2022 | 176.16M |
| September 30, 2022 | 199.42M |
| June 30, 2022 | 222.53M |
| March 31, 2022 | 248.94M |
| December 31, 2021 | 271.79M |
| September 30, 2021 | 261.17M |
| June 30, 2021 | 277.09M |
| March 31, 2021 | 298.66M |
| December 31, 2020 | 309.86M |
| September 30, 2020 | 107.74M |
| June 30, 2020 | 119.08M |
| March 31, 2020 | |
| December 31, 2019 | 14.52M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 849.72M |
| Protagonist Therapeutics, Inc. | 1.085B |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 207.98M |
| Total Liabilities (Quarterly) | 14.31M |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 15.80 |
| Net Debt Paydown Yield | 0.02% |